CNS & Neurological Disorders - Drug Targets
Title:Meet the Editorial Board Member
Volume: 21 Issue: 8
Author(s): Claire F. Evans
Affiliation:
Export Options
About this article
Cite this article as:
Evans F. Claire, Meet the Editorial Board Member, CNS & Neurological Disorders - Drug Targets 2022; 21 (8) . https://dx.doi.org/10.2174/187152732108220420090401
DOI https://dx.doi.org/10.2174/187152732108220420090401 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
IL-27: Friend or Foe in the Autoimmune Diseases
Current Immunology Reviews (Discontinued) Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease
Current Neuropharmacology Recent Trials for FTY720 (Fingolimod): A New Generation of Immunomodulators Structurally Similar to Sphingosine
Reviews on Recent Clinical Trials Immune Deviation Strategies in the Therapy of Psoriasis
Current Drug Targets - Inflammation & Allergy The Role of microRNA in Ischemic and Hemorrhagic Stroke
Current Drug Delivery Viral Infection - A Cure for Type 1 Diabetes?
Current Medicinal Chemistry Applications of iTRAQ and TMT Labeling Techniques to the Study of Neurodegenerative Diseases
Current Protein & Peptide Science MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies
Current Medicinal Chemistry Neurotrophic and Neuroprotective Effects of Muscle Contraction
Current Pharmaceutical Design A Systems Biology Approach for miRNA-mRNA Expression Patterns Analysis in Rheumatoid Arthritis
Combinatorial Chemistry & High Throughput Screening Possible Roles of Microglial Cells for Neurotoxicity in Clinical Neurodegenerative Diseases and Experimental Animal Models
Inflammation & Allergy - Drug Targets (Discontinued) Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents
Current Medicinal Chemistry Current Research on Opioid Receptor Function
Current Drug Targets Nerve Growth Factor: A Focus on Neuroscience and Therapy
Current Neuropharmacology Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope
Current Cancer Therapy Reviews 3D-Pharmacophere Models for CC Chemokine Receptor 1 Antagonists
Medicinal Chemistry Cannabinoids, Immune System and Cytokine Network
Current Pharmaceutical Design Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as A Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Glutamate in CNS Neurodegeneration and Cognition and its Regulation by GCPII Inhibition
Current Medicinal Chemistry Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
CNS & Neurological Disorders - Drug Targets